Resveratrol

C-C motif chemokine ligand 2 ; Homo sapiens







25 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33325132 Resveratrol treatment reduces expression of MCP-1, IL-6, IL-8 and RANTES in endometriotic stromal cells. 2021 Jan 5
2 34299258 Resveratrol Is a Natural Inhibitor of Human Intestinal Mast Cell Activation and Phosphorylation of Mitochondrial ERK1/2 and STAT3. 2021 Jul 16 1
3 34830366 Natural Compound Resveratrol Attenuates TNF-Alpha-Induced Vascular Dysfunction in Mice and Human Endothelial Cells: The Involvement of the NF-κB Signaling Pathway. 2021 Nov 19 2
4 32322697 Resveratrol plus carboxymethyl-β-glucan in infants with common cold: A randomized double-blind trial. 2020 Apr 1
5 32733952 Resveratrol Improves Hepatic Redox Status and Lipid Balance of Neonates with Intrauterine Growth Retardation in a Piglet Model. 2020 1
6 30366059 Resveratrol decreases the expression of genes involved in inflammation through transcriptional regulation. 2019 Jan 2
7 30886977 Resveratrol displays anti-inflammatory properties in an ex vivo model of immune mediated inflammatory arthritis. 2018 2
8 28278187 Resveratrol ameliorates the chemical and microbial induction of inflammation and insulin resistance in human placenta, adipose tissue and skeletal muscle. 2017 1
9 28546852 The Repeated Administration of Resveratrol Has Measurable Effects on Circulating T-Cell Subsets in Humans. 2017 1
10 27145432 Resveratrol Prevents Tumor Growth and Metastasis by Inhibiting Lymphangiogenesis and M2 Macrophage Activation and Differentiation in Tumor-associated Macrophages. 2016 May-Jun 1
11 25890876 Resveratrol attenuates CXCL11 expression induced by proinflammatory cytokines in retinal pigment epithelial cells. 2015 Aug 1
12 25926797 Obesity and inflammation: reduced cytokine expression due to resveratrol in a human in vitro model of inflamed adipose tissue. 2015 1
13 26190093 Exploring new ways of regulation by resveratrol involving miRNAs, with emphasis on inflammation. 2015 Aug 1
14 23981542 Resveratrol attenuates the release of inflammatory cytokines from human bronchial smooth muscle cells exposed to lipoteichoic acid in chronic obstructive pulmonary disease. 2014 Feb 1
15 24584901 Inhibitory effects of resveratrol on foam cell formation are mediated through monocyte chemotactic protein-1 and lipid metabolism-related proteins. 2014 May 6
16 22748497 Resveratrol induces nuclear factor-κB activity in human cardiac cells. 2013 Sep 10 2
17 23661232 Inhibitory effects of resveratrol on MCP-1, IL-6, and IL-8 production in human coronary artery smooth muscle cells. 2013 Sep 5
18 21186817 Effects of polyphenolic compounds on tumor necrosis factor-α (TNF-α)-induced changes of adipokines and oxidative stress in 3T3-L1 adipocytes. 2011 Jan 26 2
19 21419119 Extracellular HIV-1 Tat upregulates TNF-α dependent MCP-1/CCL2 production via activation of ERK1/2 pathway in rat hippocampal slice cultures: inhibition by resveratrol, a polyphenolic phytostilbene. 2011 Jun 3
20 21878744 Resveratrol inhibits monocytic cell chemotaxis to MCP-1 and prevents spontaneous endothelial cell migration through Rho kinase-dependent mechanism. 2011 5
21 20709957 Trans- but not cis-resveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-κB activation and peroxisome proliferator-activated receptor-gamma upregulation. 2010 Sep 15 1
22 20943792 Quercetin is equally or more effective than resveratrol in attenuating tumor necrosis factor-{alpha}-mediated inflammation and insulin resistance in primary human adipocytes. 2010 Dec 1
23 18291098 Anti-inflammatory effect of resveratrol on TNF-alpha-induced MCP-1 expression in adipocytes. 2008 May 2 5
24 17191021 Resveratrol, a polyphenolic phytostilbene, inhibits endothelial monocyte chemotactic protein-1 synthesis and secretion. 2007 8
25 17499741 Resveratrol inhibits expression and binding activity of the monocyte chemotactic protein-1 receptor, CCR2, on THP-1 monocytes. 2007 Nov 3